OM1

OM1

Population Health & Healthcare Analytics

About OM1

OM1 is a pioneering healthcare AI and real-world evidence company that has developed the PhenOM foundation model, trained on over 1 billion patient-years of data. The company was founded to close the gap between what healthcare demands and what traditional evidence can deliver. OM1's technology enables digital patient phenotyping, medical event prediction, and outcomes forecasting to help healthcare leaders make data-driven decisions with confidence. The company's platform combines frontier AI technology with comprehensive real-world data covering 350M+ patients from EMR, claims, and specialty networks. OM1 holds 10+ patents in digital patient phenotyping, subtyping, outcomes measurement, and healthcare AI explainability. The company has demonstrated clinical impact through randomized controlled trials and has completed the largest AI-processed study with a successful regulatory submission for a new label indication. OM1 serves three primary markets: life sciences companies seeking to accelerate drug discovery and generate regulatory-ready evidence; healthcare providers looking to improve screening, patient finding, and quality scores; and payers aiming to identify high-risk members and measure ROI of care management programs. The company's solutions include patient finding and outcomes prediction, clinical registries and automated studies, clinical datasets and insights, and scientific consulting services. With experience in 300+ registries and observational studies, OM1 combines cross-functional expertise in data science, epidemiology, clinical research, and AI to transform how real-world evidence is generated and applied across the healthcare ecosystem.

Mission & Story

Mission

OM1 was founded to close the gap between what healthcare demands and what traditional evidence can deliver.

Founding Story

OM1 was founded to address the gap between healthcare's evidence needs and what traditional methods could provide. The company's cross-functional team of scientists, clinicians, and engineers bring deep expertise in outcomes measurement, AI, and real-world data.

Clinical Focus

Medical conditions and clinical areas addressed by OM1.

Hidradenitis suppurativaFabry DiseaseImmunology conditionsOncologyRare diseasesCardiovascular outcomes

Who It Serves

Life Sciences/BiopharmaHealth SystemsSpecialty NetworksMedical AssociationsPayersGovernment

Milestones & Awards

Recent Milestones

Frost & Sullivan 2025 Technology Innovation Leadership Recognition for shaping the future of RWE with innovative AI solutions for immunology and oncology. Novartis and AAD partnership to improve outcomes for HS patients using PhenOM.

Awards & Recognition

Frost & Sullivan 2025 Technology Innovation Leadership Recognition. Award-winning AI platform. Original patent holder for digital patient phenotyping.

Key Partnerships

NovartisAmerican Academy of Dermatology (AAD)

Company Details

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

HIPAA

Official Sources

Last updated Jun 30, 2026

Similar Companies in this Market

View all 56
16 Bit Inc

16 Bit Inc

AI-driven opportunistic screening platform to improve population bone health and healthcare quality.

1m

1m

1m empowers healthcare leaders to make confident, risk-aware decisions using continuously updated, quantified risk intelligence.

AgileMD

AgileMD

AgileMD provides AI-powered clinical decision support tools including eCART, an FDA-cleared early warning system for clinical deterioration, and integrated clinical pathways that embed evidence-based protocols directly into EHR workflows for hospitals and health systems.

Algorex Health

Algorex Health

N1 Health (formerly Algorex Health) is an applied AI platform that predicts the right individuals to engage with the right interventions to drive better health outcomes. The platform combines data, models, and technology to generate member-level predictions for healthcare organizations.

Arbital Health

Arbital Health

Arbital Health provides the first AI-powered platform built for value-based care by industry-leading healthcare actuaries. The company helps providers, payers, and VBC enablers proactively manage risk contracts through actuarial-grade analytics and conversational AI.

Arcadia.io

Arcadia.io

acquired · 360 employees

Arcadia is a healthcare data analytics platform trusted by top payers and providers to deliver insights where they matter most.

Azara Healthcare

Azara Healthcare

Azara Healthcare provides population health management solutions for safety-net providers, community health centers, and physician practices. The company's flagship platform, Azara DRVS, aggregates clinical, claims, and social determinants data to enable quality reporting, care coordination, and value-based care performance.

Carrot Health

Carrot Health

Carrot Health provides AI-powered consumer health intelligence and predictive analytics for healthcare organizations. The company helps payers, providers, and life sciences companies identify, engage, and serve patients more effectively through data-driven insights.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.